Clinical Trial Update: 3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating three anthracyclines with two consolidation strategies using different cytarabine (ARA-C) doses and maintenance in adults with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Doxorubicin (doxorubicin)
• Idarubicin (idarubicin)

Snippet

Sponsor: National Research Center for Hematology, Russia | Conditions: Acute Myeloid Leukemia | Phase 4 | Status: UNKNOWN